Pure Global

IMAT's blood glucose test tablets - Taiwan Registration 603c03a00a9eb7edc3e3e4f9f4889f19

Access comprehensive regulatory information for IMAT's blood glucose test tablets in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 603c03a00a9eb7edc3e3e4f9f4889f19 and manufactured by EPS BIO TECHNOLOGY CORP.. The authorized representative in Taiwan is EPS BIO TECHNOLOGY CORP..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
603c03a00a9eb7edc3e3e4f9f4889f19
Registration Details
Taiwan FDA Registration: 603c03a00a9eb7edc3e3e4f9f4889f19
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

IMAT's blood glucose test tablets
TW: ๅฎœ็‘ชๆฐ่ก€็ณ–ๆธฌ่ฉฆ็‰‡
Risk Class 2

Registration Details

603c03a00a9eb7edc3e3e4f9f4889f19

Company Information

Taiwan, Province of China

Product Details

It is suitable for in vitro measurement of glucose content in fresh microvascular whole blood samples, and can be used with Fuyong Ilimax, IMA Professional and IMA Smart blood glucose machines, not suitable for newborn detection.

A Clinical chemistry and clinical toxicology

A.1345 Glucose Test System

QMS/QSD;; ๅœ‹็”ข

Dates and Status

Nov 22, 2022

Nov 22, 2027